Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Agulnik

Showing results (111-120 of 112) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 112 results.
Lancet (London, England)|March 30, 2024
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trialSandra P D'Angelo, Dejka M Araujo, Albiruni R Abdul Razak, et al.
Nature Communications|June 15, 2022
Clinical genomic profiling in the management of patients with soft tissue and bone sarcomaMrinal M Gounder, Narasimhan P Agaram, Sally E Trabucco, et al.
Pageof 12

Showing results (111-120 of 112) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 112 results.
Lancet (London, England)|March 30, 2024
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trialSandra P D'Angelo, Dejka M Araujo, Albiruni R Abdul Razak, et al.
Nature Communications|June 15, 2022
Clinical genomic profiling in the management of patients with soft tissue and bone sarcomaMrinal M Gounder, Narasimhan P Agaram, Sally E Trabucco, et al.
Pageof 12